Literature DB >> 26828673

Interdigitation Zone Band Restoration After Treatment of Diabetic Macular Edema.

Satoshi Serizawa1, Kishiko Ohkoshi1, Yuko Minowa1, Kumiko Soejima2.   

Abstract

PURPOSE: To investigate whether the integrity of the interdigitation zone band, the ellipsoid zone band, and the external limiting membrane are reliable markers of treatment outcome in diabetic macular edema (DME).
METHODS: In this retrospective study, we examined 41 treatment-naïve eyes (38 patients) with DME that were treated with laser therapy, pharmacotherapy, and/or vitrectomy. Best-corrected visual acuity and the integrity of the interdigitation zone band, the ellipsoid zone band, and the external limiting membrane were assessed before treatment and at 3, 6, and 12 months after DME treatment.
RESULTS: One year after treatment, the external limiting membrane, ellipsoid zone band, and interdigitation zone band were completely visible in 30 (73.2%), 24 (58.5%), and 2 (4.9%) eyes, respectively. Interdigitation zone band status improved significantly (P = 0.005) 1 year after treatment. The interdigitation zone did not improve in the absence of the ellipsoid zone band. Likewise, ellipsoid zone status did not improve in the absence of the external limiting membrane at any time after treatment.
CONCLUSION: The results of this study show that restoration of the interdigitation zone band constitutes a very sensitive marker of DME treatment outcome when the ellipsoid zone band is visible before treatment.

Entities:  

Keywords:  Diabetic macular edema; diabetic retinopathy; ellipsoid zone; interdigitation zone; optical coherence; tomography

Mesh:

Substances:

Year:  2016        PMID: 26828673     DOI: 10.3109/02713683.2015.1113430

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

1.  Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.

Authors:  Hassan Khojasteh; Hamid Riazi-Esfahani; Elias Khalili Pour; Hooshang Faghihi; Fariba Ghassemi; Fatemeh Bazvand; Raziyeh Mahmoudzadeh; Mirataollah Salabati; Masoud Mirghorbani; Mohammad Riazi Esfahani
Journal:  Int Ophthalmol       Date:  2019-11-11       Impact factor: 2.031

2.  OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.

Authors:  Yi-Ting Hsieh; Minhaj Nur Alam; David Le; Chia-Chieh Hsiao; Chang-Hao Yang; Daniel L Chao; Xincheng Yao
Journal:  Ophthalmol Retina       Date:  2019-05-07

3.  Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy

Authors:  Seher Eraslan; Özlem Yıldırım; Özer Dursun; Erdem Dinç; Gülhan Orekici Temel
Journal:  Turk J Ophthalmol       Date:  2020-06-27

4.  Choroidal Hyperreflective Foci: A Novel Spectral Domain Optical Coherence Tomography Biomarker in Eyes With Diabetic Macular Edema.

Authors:  Rupak Roy; Kumar Saurabh; Dhaivat Shah; Maitreyi Chowdhury; Sugandha Goel
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Jul-Aug

5.  Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study.

Authors:  Lucy J Kessler; Gerd U Auffarth; Dmitrii Bagautdinov; Ramin Khoramnia
Journal:  J Diabetes Res       Date:  2021-10-07       Impact factor: 4.011

6.  Interdigitation and Ellipsoid Zones Disruption Correlate with Visual Outcomes among Treatment-Naive Patients with Diabetic Macular Edema.

Authors:  Nardine Sharef; Rabea Kassem; Idan Hecht; Asaf Bar; Idit Maharshak; Zvia Burgansky-Eliash; Yehonatan Weinberger; Raimo Tuuminen; Asaf Achiron
Journal:  Ophthalmic Res       Date:  2020-11-20       Impact factor: 2.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.